raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:251607

Pleomorphic xanthoastrocytoma

Synonyms: PXA

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A rare astrocytoma characterized by GFAP-expressing cells with nuclear/cytoplasmic pleomorphism, xanthomatous changes, and eosinophilic granular bodies surrounded by a reticulin network. Pleomorphic xanthoastrocytoma (PXA) most often has cerebral hemispheres location with meningeal involvement, mainly affects younger individuals and is frequently characterized by early seizure manifestation. Extent of resection and mitotic index are important prognostic factors. PXA commonly exhibits MAPK signaling pathway genes mutations (most frequently <i>BRAFV600E</i>), often combined with <i>CDKN2A/B</i> homozygous deletion, and a specific DNA methylation profile. The tumor corresponds to WHO grade 2 or grade 3, mainly depending on the mitotic index and Ki-67 expression.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPleomorphic xanthoastrocytomaPXA
frXanthoastrocytome pléomorphe= en
deXanthoastrozytom, pleomorphes= en
esXantoastrocitoma pleomórfico= en
itXantoastrocitoma pleomorfo= en
nlPleomorf xanthoastrocytoomPXA · Pleiomorf xanthoastrocytoom
ptXantoastrocitoma pleomórfico= en
plŻółtakogwiaździak pleomorficzny= en
csPleomorfní xanthoastrocytom= en
ukПлеоморфна ксантоастроцитома= en
zh多形性黄色星形细胞瘤多形性黄色星形细胞瘤
trPleomorfik ksantoastrositom= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C71.9NTBTindexvalidated
ICD-112A00.0YNTBTindexvalidated
ICD-11XH99U2Especificvalidated
MONDO0016690Evalidated
UMLSC0334586Evalidated
GARD10631Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence<1 / 1 000 0000.01 / 100 000EuropeValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card